Warfarin Sodium is a widely used oral anticoagulant (blood thinner) that helps prevent and treat thromboembolic disorders such as deep vein thrombosis, pulmonary embolism, and stroke by inhibiting the synthesis of vitamin K-dependent clotting factors in the liver. Its history dates back to the 1920s when cattle experienced severe bleeding after consuming spoiled sweet clover hay, leading researchers to discover dicoumarol, a natural anticoagulant. In the 1940s, scientists at the Wisconsin Alumni Research Foundation developed a more potent synthetic derivative named warfarin, derived from the foundation's acronym (WARF). Initially introduced as a rodenticide in 1948, warfarin was later approved for human medical use in 1954 and became one of the most widely prescribed anticoagulant medications worldwide. Today, Warfarin Sodium remains an important treatment option due to its proven effectiveness, extensive clinical experience, and cost-effectiveness in managing blood clot-related conditions.
